Author

Y. Morioka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:virus· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1 Assay:metagenomics· 1

Frequent Co-Authors

T. Fukuhara· 3 shared Y. Matsuura· 3 shared C. Ono· 2 shared H. Ito· 2 shared K. Shirakawa· 2 shared K. Yoshimatsu· 2 shared L. Wang· 2 shared R. Suzuki· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

T. Fukuhara

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection

T. Tamura, H. Ito, S. Torii, L. Wang, S. Tsujino, A. Kamiyama, Y. Oda, Y. Morioka, S. Suzuki, K. Shirakawa, K. Sato, K. Yoshimatsu, Y. Matsuura, S. Iwano, S. Tanaka, T. Fukuhara

This study introduces AkaBLI, a method using Akaluc bioluminescence to track SARS-CoV-2 infection in vivo with higher sensitivity than NanoLuc, showing its utility in monitoring viral dynamics and vaccine efficacy.

bioRxiv · Oct 12, 2023 · PreprintMicrobiology

Virological characteristics of SARS-CoV-2 BA.2 variant

D. Yamasoba, I. Kimura, H. Nasser, Y. Morioka, N. Nao, J. Ito, K. Uriu, M. Tsuda, J. Zahradnik, K. Shirakawa, R. Suzuki, M. Kishimoto, Y. Kosugi, K. Kobiyama, T. Hara, , Sawa

This study compares the virological characteristics of SARS-CoV-2 BA.2 and BA.1 variants, finding BA.2 has higher transmissibility, different antigenicity, greater replicative capacity, and higher pathogenicity in hamsters.

bioRxiv · Feb 14, 2022Microbiology

Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction

S. Torii, C. Ono, R. Suzuki, Y. Morioka, I. Anzai, Y. Fauzyah, Y. Maeda, W. Kamitani, T. Fukuhara, Y. Matsuura

This study develops a PCR-based reverse genetics system for SARS-CoV-2 using CPER to generate infectious clones with high accuracy and titer.

bioRxiv · Sep 23, 2020Microbiology

Various miRNAs are involved in efficient HCV replication

C. Ono, T. Fukuhara, S. Li, J. Wang, A. Sato, T. Izumi, Y. Fauzyah, T. Yamamoto, Y. Morioka, N. V. Dokholyan, D. M. Standley, Y. Matsuura

This study identifies miRNAs other than miR-122 that support HCV replication in non-hepatic cells by interacting with the viral 5UTR and stabilizing the IRES structure.

PLOS Pathogens · Jun 23, 2020Peer-reviewedMicrobiology